Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7842]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
FDA approves eflornithine for adult and paediatric patients with high-risk neuroblastoma
FDA approves eflornithine for adult and paediatric patients with high-risk neuroblastoma
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
ASH 2023: Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax
ASH 2023: Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax
ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib
ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment...
ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments
ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments
ASH 2023: Collaborators leads to new treatment options for advanced myelofibrosis, other blood malignancies
ASH 2023: Collaborators leads to new treatment options for advanced myelofibrosis, other blood malignancies
FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer
FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic urothelial cancer
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
Study reports progress in long-term protection against ovarian cancer tumours
Study reports progress in long-term protection against ovarian cancer tumours

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation